Abstract
Due to the directed way of testing chemical compounds' in drug research and development many projects fail because serious adverse effects and toxicity are discovered too late, and many existing prospective activities remain unstudied. Evaluation of the general biological potential of molecules is possible using a computer program PASS that predicts more than 780 pharmacological effects, mechanisms of action, mutagenicity, carcinogenicity, etc. on the basis of structural formulae of compounds, with average accuracy ∼85%. PASS applications to both databases of available samples included hundreds of thousands compounds, and small collections of compounds synthesized by separate medicinal chemists are described. It is shown that 880 compounds from Prestwick chemical library represent a very diverse pharmacological space. New activities can be found in existing compounds by prediction. Therefore, on this basis, the selection of compounds with required and without unwanted properties is possible. Even when PASS cannot predict very new activities, it may recognize some unwanted actions at the early stage of R&D, providing the medicinal chemist with the means to increase the efficiency of projects.
Similar content being viewed by others
References
Han van deWaterbeemd. In Abstr. XVIIth Symp. Med. Chem., Barcelona, 1–5 Sept. 2002, L10.2. Wermuth, C.G. Med. Chem. Res. 10 (2001) 431.
Wermuth, C.G. Med. Chem. Res. 10 (2001) 431.
Poroikov, V., Akimov, D., Shabelnikova, E. and Filimonov, D. SAR and QSAR in Environm. Res. 12 (2001) 327.
Poroikov, V. and Filimonov, D., In Kartsev, V.G. and Tolstikov, G.A. (Eds.)., Nitrogen-containing heterocycles and alcaloides, Iridium Press, Moscow, 2001, 1, pp. 149–154.
Poroikov, V. and Filimonov, D. In Holtje, H.-D. and Sippl, W. (Eds.), Rational Approaches to Drug Design, Prous Science, Barcelona, 2001, pp. 403–407.
http://www.ibmh.msk.su/PASS
Filimonov, D., Poroikov, V., Borodina, Yu. and Gloriozova, T.J. Chem. Inf. Comput. Sci., 39, (1999) 666.
Anzali, S., Barnickel, G., Cezanne, B., Krug, M., Filimonov, D. and Poroikov, V. J. Med. Chem. 44 (2001) 2432.
Lagunin, A., Stepanchikova, A., Filimonov, D. and Poroikov, V. Bioinformatics. 16 (2000) 747.
Filimonov, D. Abstr. II Rus. Natl. Congr. ‘Man and Drugs', Moscow, 1995, pp. 62–63.
Poroikov, V., Filimonov, D., Borodina, Yu., Lagunin, A. and Kos, A.J. Chem. Inform. Comput. Sci. 40 (2000) 1349.
Poroikov, V.V., Filimonov, D.A., Ihlenfeldt, W.-D., Gloriozova, T.A., Lagunin, A.A., Borodina, Yu.V., Stepanchikova, A.V. and Nicklaus, M.C. J. Chem. Inform. Comput. Sci. 43 (2003) 228.
http://www.chembridge.com
http://www.asinex.com
http://www.specs.net
http://www.akosgmbh.de
http://www.prestwickchemical.com
Lagunin, A.A., Filimonov, D.A. and Poroikov, V.V. In Abstracts of 6th International Conference on Chemical Structures, Noordwijkerhout. 2002, pp. 25–26.
Banoglu, E., Okcelik, B., Kupeli, E., Unlu, S., Yesilada, E. and Sahin, M.F. In Abstr. XVIIth Symp. Med. Chem., Barcelona, 1–5 Sept. 2002, P127.
Zimmermann, J., Buchdunger E. and Mantley P. In Abstr. XVIIth Symp. Med. Chem., Barcelona, 1–5 Sept. 2002, L19.
Makarov, V.A. and Mollmann, U. In Abstr. XVIIth Symp. Med. Chem., Barcelona, 1–5 Sept. 2002, P.351.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poroikov, V., Filimonov, D. How to acquire new biological activities in old compounds by computer prediction. J Comput Aided Mol Des 16, 819–824 (2002). https://doi.org/10.1023/A:1023836829456
Issue Date:
DOI: https://doi.org/10.1023/A:1023836829456